D.E. Shaw & Co’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,875
| Closed | -$54.3K | – | 3188 |
|
|
2025
Q1 | $54.3K | Sell |
14,875
-85,492
| -85% | -$312K | ﹤0.01% | 2880 |
|
|
2024
Q4 | $474K | Buy |
100,367
+30,671
| +44% | +$145K | ﹤0.01% | 2427 |
|
|
2024
Q3 | $649K | Buy |
69,696
+43,958
| +171% | +$409K | ﹤0.01% | 2368 |
|
|
2024
Q2 | $148K | Buy |
+25,738
| New | +$148K | ﹤0.01% | 2865 |
|
|
2022
Q2 | – | Sell |
-19,855
| Closed | -$302K | – | 4225 |
|
|
2022
Q1 | $302K | Buy |
19,855
+5,687
| +40% | +$86.5K | ﹤0.01% | 3442 |
|
|
2021
Q4 | $324K | Buy |
+14,168
| New | +$324K | ﹤0.01% | 3285 |
|